Coloplast A/S
Healthcare · DKK · XETRA
Price
DKK 397.7
Cap
DKK 90.19B
Earnings
—
30d Trend
-1.5%
31% annualised over 90 days
BRAIN47 SIGNAL
Raw weighted: 55×Macro 0.99 (−1%)=54
RISK
QUALITY
MOMENTUM
TECHNICAL
FUNDAMENTALS
Macro: neutral (×0.99) - Fear/Greed: 65 (Greed) - Data: 100%
BRAIN47 HORIZON ANALYSIS
12-24 month value thesis — fundamentally underpriced
BRAIN47'S ASSESSMENT
I rate Coloplast A/S at 54/100 — a MODERATE reading on the Brain47 Signal. The strongest factor is fundamentals at 85/100. I classify this as a income position with the strongest thesis on a long-term horizon.
PAST PERFORMANCE
1 MONTH
+0.1%
3 MONTHS
-16.2%
12 MONTHS
-34.7%
Trailing returns — past performance, not a projection.
DETAILED ANALYSIS
12-24 month value thesis — fundamentally underpriced. Fundamentals (85) and Quality (76) are the primary strengths. I note that momentum is the weakest area at 13/100 — this warrants monitoring. Historical volatility is moderate at 31%. I classify this as an income position — the 15.0% yield combined with the dividend profile makes it suitable for income generation.
Want full analysis on every stock?
Brain47 provides AI-powered research across 72,000+ instruments. Stocks, ETFs, REITs and more.
Join Brain47 — FreeGenerated by Brain47 AI. Educational research only. Not financial advice. Brain47 is not authorised by the FCA to provide investment advice.